Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCRT1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,598
Award facts
- Contract value 100% obligated
- $20,598.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,598.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award was made on January 6, 2026, with an ultimate completion date of January 28, 2026, under a firm fixed-price delivery order contract type. No set-aside designation was utilized for this procurement, indicating the award was made through open competition. DMS Pharmaceutical Group Inc. will perform the work at its facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036. The PPV-G GEN V represents a strategic $30.3 billion acquisition strategy designed to provide pharmaceutical and medical consumable supplies to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across multiple therapeutic categories, including specialty biologics such as Stelara, positions it as a critical supplier within the Department of Defense's pharmaceutical supply chain. No subcontractors have been identified for this delivery order.
Quick answers
Who was awarded contract SPE2DR26FCRT1?
SPE2DR26FCRT1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCRT1 worth?
The government has obligated $20,598 on SPE2DR26FCRT1.
Is contract SPE2DR26FCRT1 an order under another contract?
Yes. SPE2DR26FCRT1 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRT1 competed?
The extent of competition for SPE2DR26FCRT1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award